Interesting post from Yahoo.
Analysts updated
by: muchomuscles
Long-Term Sentiment: Strong Buy 05/18/05 02:59 pm
Msg: 343920 of 343946
All three analysts covering Avanir came out with updated reports today. I am reporting only on their comments as it pertains to the Yak sack.
Punk Ziegel…..
“We believe, although timing of the announcement caught us by surprise and it creates near-term confusion for The Street, it represents a long-term positive for the Company.”
“As this transition will not impact the timing of the NDA filing for Neurodex or the partnership discussions which are underway for the Company’s atherosclerosis program, we recommend investors to take advantage of any price weakness to buy shares of Avanir.”
Lazard.....
“We believe that a potential candidate has been targeted and that discussions have been initiated. Given that there was no forewarning of a transition offered to investors and no interim CEO appointed, the timing of the board’s decision is difficult to for us to understand. Nevertheless, we are comfortable that there are no negative implications for Neurodex and that the PBA and neuropathic pain programs remain fully intact and on schedule."
Rodman & Renshaw…..
“We were not surprised by the announcement, since AVANIR is undergoing transformation from
a drug developer to a commercial entity with the potential launch of Neurodex in early 2006. The Board is hoping to announce the successor at the helm in the very near future. While the timing of such transition never seems to satisfy everyone, we believe that the volatility experienced by the stock could subside once the new CEO announced and his vision is articulated.”
G'day, Mates.
Aussie
Australia is a beautiful place with wonderful people that just love Americans. You've got to go there some day. Give it a go Mate.
